Pharamax

estudios

Remember:

Our Research begins with YOU!

CURRENT STUDIES

Our center is conducting multiple clinical trials for patients with an active medical diagnosis in any of the conditions listed in this page.  By "active”, we mean you currently meet the criteria for your condition. By "medical diagnosis”, we mean that a diagnosis has been made by a qualified physician and there is a documented medical record of such condition.

COVID-19

  • Age Groups: 12 to 80 years of age
  • Gender: Male and Female
  • Duration: 16 weeks
  • Required Visits: 7
  • COVID-19 vaccine for patients with conditions causing immune impairment.

Learn more about this study

Cardiovascular disease, CKD and inflammation

  • Age Groups: 18 years and above
  • Gender: Males and Females
  • Duration: 4 years approximately
  • Required Visits: 21
  • For patients with established atherosclerotic cardiovascular disease, CKD and inflammation

Learn more about this study

 

Hypertension

  • Age Groups: Between 18 and 75 years of age
  • Gender: Males and Females
  • Duration: 177 semanas aprox.
  • Required Visits: 32
  • For patients with hypertension not adequately controlled

Learn more about this study 

Major depressive disorder (1)

  • Age Groups: Between 18 and 74 years of age
  • Gender: Male and Female
  • Duration: 52 weeks
  • Required Visits: 33
  • Adults with MDD and moderate to severe Anhedonia and inadequate response to current antidepressant

Learn more about this study

Major depressive disorder (2)

  • Age Groups: 18 - 74 years of age
  • Gender: Male and Female
  • Duration: 52 weeks
  • Required Visits: 33
  • Adults with MDD with moderate to severe anhedonia and inadequate response to current antidepressant

Learn more about this study

 

Major depressive disorder (3)

  • Age Groups: 18 - 74 años de edad
  • Gender: Male and Female
  • Required Visits: 32
  • For adults with MDD with moderate to severe Anhedonia and inadequate response to current antidepress

Learn more about this study

Schizophrenia

  • Age Groups: 18 to 80 years of age
  • Gender: Male and Female
  • Duration: 16 weeks
  • Required Visits: 7
  • For adults with experimental negative symptoms of schizophrenia.

Learn more about this study

To learn about eligibility criteria and compensation regarding above listed trials please call us at 305.262.4321 or 305.262.4322, Monday through Friday between 7:00 AM and 3:00 PM. 

If you or someone you know wants to participate, or your doctor and family members or friend wants to learn more about these studies, please contact us using the telephone numbers above provided.  

Other assessments will be done at the time of your call or visit to determine your eligibility and future participation for the study in which you consented to participate.